Factor 21, Inc. is a developer of creative and innovative solutions for today’s business analysis challenges (i.e., messy data and the need for data analysis and insight). Factor 21 provides management and executive level experience in developing data based strategies, and quantitative analysis for marketing, sales, telemarketing, database marketing, and systems organizations. Expertise in data mining and business data applications has been applied to the financial services, health care, publishing, telecommunications, and consumer package goods industries. Factor 21, Inc. was established in 1999.
About the founder: Lou Schwarz is the Chief Data Scientist and Managing Director of Factor 21, Inc., a business intelligence and systems integration consultancy servicing organizations as diverse as National Science Foundation, Unilever, National Institutes of Health, Sears, JCAHO, Fujisawa Pharmaceuticals, the SAS Institute, and the U.S. Census Bureau. Lou’s work has been applied to a variety of projects from large scale labor economic data analysis to sales force improvement to electronic publishing systems. Lou’s current projects are in support of the STAR Metrics Project (a joint NSF/NIH project) and the National R&D Dashboard. Prior to Factor 21, Lou spent a number of years at such companies as Zurich Financial, ProFunds/ProShares, AT&T, American Express, Time Inc., the consulting firm Management Science Associates, and the Rapp Collins direct marketing agency, where he was Senior Vice President. At those companies Lou’s statistical analysis and database expertise were applied to marketing and sales analysis, e-commerce, customer analysis, and the predictive modeling of customer behavior.
Lou is active in the Direct Marketing Association, co-authored the DMA’s book “Research and the Customer Life Cycle,” and has published in the fields of Systems, Economics, Direct Marketing, Demography, and Social Psychology.
Lou received an MSc. from the London School of Economics, post-graduate training in Survey Research from the University of Michigan, and a BA from Boston University.
Presentation at NIH